• Jacobson Pharma will hold its 2026 annual general meeting via virtual meeting on Aug. 11, 2026.
• Shareholders will vote on adopting audited consolidated financial statements and related reports for the year ended March 31, 2026.
• Final dividend proposed at HK 4.75 cents per share.
• Board seeks mandates to repurchase up to 10% of issued shares, issue up to 20% of issued shares, extend issuance mandate by repurchased shares.
• Other items include re-electing two independent non-executive directors, setting directors’ remuneration, re-appointing KPMG as auditor.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Jacobson Pharma Corporation Ltd. published the original content used to generate this news brief via IIS, the regulatory disclosure system operated by the Hong Kong Stock Exchange (HKex) (Ref. ID: HKEX-EPS-20260716-12247277), on July 16, 2026, and is solely responsible for the information contained therein.